This systematic review and meta-analysis evaluates whether, for patients with poorly controlled asthma, switching to single inhaler combination budesonide-formoterol maintenance and reliever therapy is associated with longer time to first… Click to show full abstract
This systematic review and meta-analysis evaluates whether, for patients with poorly controlled asthma, switching to single inhaler combination budesonide-formoterol maintenance and reliever therapy is associated with longer time to first severe asthma exacerbation compared with a step up or continuation of Global Initiative for Asthma treatment step with maintenance inhaled corticosteroid–long-acting β2-agonist plus short-acting β2-agonist reliever.
               
Click one of the above tabs to view related content.